Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Isabel Anzola"'
Autor:
Gianluca Iacobellis, Maria A. Urrutia, Patricia C. Gomez, Juan D. Palacios, Priyathama Vellanki, Karla W. Z. Coronado, Georgia Davis, Francisco J. Pasquel, Rodolfo J. Galindo, Limin Peng, Bonnie S. Albury, Isabel Anzola, Javier M. Farias, Guillermo E. Umpierrez, Ajay Chaudhuri, Mireya C. Perez-Guzman, Maya Fayfman, Saumeth Cardona, Alexandra Migdal
Publikováno v:
Diabetes Obes Metab
AIM: To compare a glucagon-like peptide-1 receptor agonist with basal insulin at hospital discharge in patients with uncontrolled type 2 diabetes in a randomized clinical trial. METHODS: A total of 273 patients with glycated haemoglobin (HbA1c) 7%–
Autor:
Priyathama Vellanki, Francisco J. Pasquel, Guillermo E. Umpierrez, Maria A. Urrutia, Isabel Anzola, Limin Peng, Saumeth Cardona, Sara M. Alexanian, David S. Baldwin, Neda Rasouli
Publikováno v:
Diabetes Obes Metab
AIMS The use of incretin-based therapy, rather than or complementary to, insulin therapy is an active area of research in hospitalized patients with type 2 diabetes (T2D). We determined the glycaemic efficacy and safety of linagliptin compared to a b
Autor:
null Francisco J Pasquel, null Maria A Urrutia, null Saumeth Cardona, null K. Walkiria Zamudio Coronado, null Bonnie Albury, null M. Citlalli Perez‐Guzman, null Rodolfo J Galindo, null Ajay Chaudhuri, null Gianluca Iacobellis, null Juan Palacios, null Javier M Farias, null Patricia Gomez, null Isabel Anzola, null Priyathama Vellanki, null Maya Fayfman, null Georgia M Davis, null Alexandra L Migdal, null Limin Peng, null Guillermo E Umpierrez
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e55a3fed93d2929e2339fa23e1ab26ad
https://doi.org/10.1111/dom.14347/v3/response1
https://doi.org/10.1111/dom.14347/v3/response1
Autor:
Rodolfo J. Galindo, Georgia Davis, Francisco J. Pasquel, Maya Fayfman, Patricia C. Gomez, Gianluca Iacobellis, Maria A. Urrutia, Saumeth Cardona, Priyathama Vellanki, Bonnie S. Albury, Javier M. Farias, Ajay Chaudhuri, Isabel Anzola, Limin Peng, Alexandra Migdal, M. Citlalli Perez-Guzman, Juan D. Palacios, K. Walkiria Zamudio Coronado, Guillermo E. Umpierrez
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b96d5f9ec4d809f85637109d31142a6b
https://doi.org/10.1111/dom.14347/v2/response1
https://doi.org/10.1111/dom.14347/v2/response1
Autor:
Liliana Castro Luque, Humberto Bolognini Garrido, R.I. Herrera, M.A. Rojas, Emilia Isabel Anzola de Partidas
Publikováno v:
Gaceta Técnica, Vol 7, Iss 1 (2008)
En esta investigación se estudio el alcance de los cloruros en un lapso de 4 años y la actividad electroquímica en vigas de concreto armado expuestas en ambiente marino y sometido a diferentes tiempos de curado y elaborados con distintos estados s
Externí odkaz:
https://doaj.org/article/2133fdf9db8a4449b64cfb25d5465617
Autor:
Kathleen Dungan, David H. Wesorick, Francisco J. Pasquel, Tim W. Bodnar, Israel Hodish, Kwame Osei, Limin Peng, Roma Y. Gianchandani, Daniel J. Rubin, Vijay Balakrishnan, Patricia C. Gomez, Isabel Anzola, Guillermo E. Umpierrez
Publikováno v:
The Lancet Diabetes & Endocrinology. 5:125-133
The role of incretin-based drugs in the treatment of patients with type 2 diabetes admitted to hospital has not been extensively assessed. In this study, we compared the safety and efficacy of a dipeptidyl peptidase-4 inhibitor (sitagliptin) plus bas
Autor:
Alexandra Migdal, M. Cecilia Lansang, Isabel Anzola, Rodolfo J. Galindo, J. Sonya Haw, Priyathama Vellanki, Guillermo E. Umpierrez, Georgia Davis, Ryan C. Lyerla, Bonnie S. Albury, Ameer Khowaja, Limin Peng, Maria A. Urrutia, Maya Fayfman, Francisco J. Pasquel, Saumeth Cardona, Almoutaz Shakally
Publikováno v:
Diabetes. 68
This prospective, open-label, randomized clinical trial compared the safety and efficacy of a basal bolus regimen using glargine U300 or glargine U100 for the management of general medicine and surgery patients with T2D. A total of 171 patients (age:
Autor:
Guillermo E. Umpierrez, Heqiong Wang, Francisco J. Pasquel, Isabel Anzola, Maria A. Urrutia, Maya Fayfman, Derek LeRoith
Publikováno v:
Diabetes. 68
Changes in insulin requirements after hospital discharge in insulin-treated patients with type 2 diabetes (T2D) are not known. We conducted a pooled analysis of 4 randomized clinical trials with 3-month follow-up data to determine changes in insulin
Autor:
Maria A. Urrutia, Rodolfo J. Galindo, Ashley A. Johnson, Priyathama Vellanki, Limin Peng, Isabel Anzola, Francisco J. Pasquel, Bonnie S. Albury, Cesar Zambrano, Alexandra Migdal, Georgia Davis, Maya Fayfman, Ameer Khowaja, Saumeth Cardona, Guillermo E. Umpierrez
Publikováno v:
Diabetes. 68
Background: There are no published studies assessing the accuracy of the FreeStyle Libre CGM in the inpatient management of patients with type 2 diabetes (T2D). Methods: Adult patients (n: 81) on basal-bolus insulin therapy with a target BG between 7
Autor:
Guillermo E. Umpierrez, Francisco J. Pasquel, Rodolfo J. Galindo, Isabel Anzola, Maria A. Urrutia, Heqiong Wang, Maya Fayfman, Saumeth Cardona
Publikováno v:
Diabetes. 68
Management of hospitalized older adults (> 65 years) with T2D is challenging and associated with increased risk of hypoglycemia. Incretin-based therapy with DPP-4i and GLP-1RA have been shown to be safe and efficacious in hospitalized patients with m